Skip to content
Home/Companies/Biotech/Iscaff Pharma

Iscaff Pharma

Biotech·Sweden·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns Iscaff Pharma?

Iscaff Pharma is a Swedish Biotech company, currently owned by GU Ventures since 2017.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
SimSen Diagnostics
Active
MedTechSweden· 2020
Hydroc Energy Storage
Active
ClimateTechSweden· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Iscaff Pharma?

Iscaff Pharma is currently owned by GU Ventures, through GU Ventures Evergreen, since 2017.

When did GU Ventures acquire Iscaff Pharma?

GU Ventures acquired Iscaff Pharma in 2017.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue